Evidence map›Paper›PMID 36685474›Full record

ArticleHeliyon2023

Sajedul Islam, Dipty Rani Bhowmik, Sourav Roy, Md Sadikur Rahman Shuvo, Rahima Begum, Maruful Hasan, Mohammad Tohidul Amin, Afm Shahid Ud Daula, Mohammad Salim Hossain

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 73% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Sajedul IslamDepartment of Pharmacy, Noakhali Science and Technology University, Noakhali, 3814, Bangladesh.
Dipty Rani BhowmikDepartment of Pharmacy, Noakhali Science and Technology University, Noakhali, 3814, Bangladesh.
Sourav RoyDepartment of Pharmacy, Noakhali Science and Technology University, Noakhali, 3814, Bangladesh.
Md Sadikur Rahman ShuvoDepartment of Microbiology, Noakhali Science and Technology University, Noakhali, 3814, Bangladesh.
Rahima BegumDepartment of Pharmacy, Noakhali Science and Technology University, Noakhali, 3814, Bangladesh.
Maruful HasanDepartment of Pharmacy, Noakhali Science and Technology University, Noakhali, 3814, Bangladesh.
Mohammad Tohidul AminDepartment of Pharmacy, Noakhali Science and Technology University, Noakhali, 3814, Bangladesh.
Afm Shahid Ud DaulaDepartment of Pharmacy, Noakhali Science and Technology University, Noakhali, 3814, Bangladesh.
Mohammad Salim HossainDepartment of Pharmacy, Noakhali Science and Technology University, Noakhali, 3814, Bangladesh.
Noakhali Science and Technology University · BD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity is a severe public health burden and a major component of metabolic syndrome. It is critical to identify treatment medicines for obesity and associated inflammation. We examined the anti-obesity and anti-inflammatory properties of

Indexed as

CholesterolMCP-1Musa acuminateObesityPPARγ

Identifiers

PMID36685474
PMCPMC9849961
OpenAlexW4313368547

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.